IQVIA (NYSE:IQV) Given New $220.00 Price Target at Guggenheim
IQVIA (NYSE:IQV – Free Report) had its target price lowered by Guggenheim from $253.00 to $220.00 in a research note released on Friday, Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities research analysts have also commented on IQV. Mizuho decreased their price target on IQVIA […]